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Abstract
A 50-year-old male was initially thought to have familial adenomatous polyposis (FAP) after innumerable small 
nodules in the upper GI tract were discovered upon endoscopic retrograde cholangiopancreatography for com-
mon bile duct stone extraction. ERCP was unsuccessful due to inability to find the major papilla amongst the 
nodules found in the duodenum. Biopsy of the nodules was consistent with nodular lymphoid hyperplasia. The 
patient was later found to have common variable immunodeficiency.
Introduction
Common variable immunodeficiency (CVID) is the second most prevalent primary immunodeficiency disorder 
after selective immunoglobulin A deficiency. Nodular lymphoid hyperplasia (NLH) of the gastrointestinal tract is 
a rare disorder associated with immunodeficiency syndromes, and characterized by numerous visible mucosal 
nodules. We report a patient with CVID and NLH initially mistaken for familial adenomatous polyposis (FAP).
Case Report
A 50-year-old male with past medical history of hypertension, polio infection, and cholecystectomy was referred 
for evaluation of persistent abdominal pain for the past 5 weeks. The patient complained of gastrointestinal reflux 
and sharp pain localized to the right upper quadrant exacerbated by fatty meals. Laboratory tests revealed an 
alkaline phosphatase (ALP) of 461 U/L, aspartate aminotransferase (AST) of 297 U/L, alanine aminotransferase 
(ALT) of 599 U/L, and a total bilirubin level of 0.6 mg/dL. Abdominal CT showed a common bile duct diameter 
of 1 cm. Initial attempt at endoscopic retrograde cholangiopancreatography (ERCP) was unsuccessful due to 
the inability to find the major papilla amongst the innumerable, 5–8-mm nodules found within the upper GI tract 
(Figure 1). 
With familial adenomatous polyposis (FAP) as the working diagnosis, repeat ERCP resulted in successful biliary 
cannulation and extraction of CBD stones with resolution of the abdominal pain and normalization of the liver 
chemistry abnormalities. Biopsy of the nodules showed prominent hyperplastic lymphoid follicles with a reduced 
number of plasma cells in the lamina propia, consistent with nodular lymphoid hyperplasia. Further lab tests 
showed low levels of IgM, IgA, and IgG (11 mg/dL [34–214], <6 mg/dL [83–407], and 246 mg/dL [680–1,445], 
respectively), and the patient was referred to an immunologist. The patient admitted to annual episodes of si-
nusitis and bronchitis, and had persistently low levels of IgA and IgG. He was diagnosed with common variable 
immune deficiency (CVID) and treatment with intravenous immunoglobulin was initiated.
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Figure 1. Endoscopic view of the second segment of the duodenum. 
Discussion
Nodular lymphoid hyperplasia (NLH) is a lymphoprolifera-
tive disease that has been reported in patients with CVID, a 
disorder characterized by impaired B cell differentiation with 
defective immunoglobulin production. It is the most preva-
lent form of severe antibody deficiency affecting both chil-
dren and adults. The clinical manifestations include recur-
rent sinopulmonary infections, autoimmune disorders, gas-
trointestinal disease, increased susceptibility to lymphoma, 
and a decreased immunogenicity to protein and polysac-
charide vaccines. Histologically, there is enlargement of the 
mucosal B cell follicles, a normal-appearing mantle zone, 
and hyperplastic lymphoid follicles with large germinal cen-
ters within the lamina propria and superficial submucosa. 
Mahsa et al reported a case of NLH mimicking FAP wherein 
they attributed the misdiagnosis to similarities in the polyp-
like appearance on endoscopy and large lymphoid follicles 
in the lamina propria on histology.1 Studies have shown that 
infection with Giardia lamblia may create a nodular mucosal 
pattern.2 
There have been suggestions that NLH is a risk factor for 
intestinal and extra-intestinal lymphoma.3 Abolhassani et al 
emphasized the need for an endoscopic surveillance proto-
col for gastric cancer in addition to immunoglobulin replace-
ment therapy. They suggest looking for risk factors in CVID 
patients, such as Helicobacter pylori infection, pernicious 
anemia, or dyspepsia, prior to initiating screening esopha-
gogastroduodenoscopy (EGD). Frequency of follow-up EGD 
would be based on site and extent of gastric lesions.3
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